This is a brand page for the REVERSIR trademark by Alnylam Pharmaceuticals, Inc.
in *********, **********, ***** ****.
Write a review about a product or service associated with this REVERSIR trademark.
Or, contact the owner Alnylam Pharmaceuticals, Inc. of the REVERSIR trademark by filing a request to communicate with
the Legal Correspondent for licensing, use, and/or questions related to the REVERSIR trademark.
On Friday, May 7, 2021,
a U.S. federal trademark registration was filed for
REVERSIR.
The USPTO has given the REVERSIR
trademark serial number of 90696853.
The current federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE.
The correspondent listed for REVERSIR is
ANN LAMPORT HAMMITTE of
********,********, ***** ****
.
The REVERSIR trademark is filed in the category of
Pharmaceutical Products
.
The description provided to the USPTO for REVERSIR
is Pharmaceutical preparations, namely, RNA therapeutics for use in the treatment of cancer, HIV, hepatitis A, hepatitis B, influenza, measles, neurodegenerative diseases, transthyretin (TTR)-mediated amyloidosis (ATTR), hemophilia, porphyria, complement-mediated disease, hypercholesterolemia, rare genetic diseases, cardio-metabolic diseases, hepatic infectious diseases, hereditary ATTR amyloidosis, rare bleeding disorders, hepatic porphyrias, alpha-1 antitrypsin deficiency, primary hyperoxaluria type 1, beta-thalassemia, iron overload disorders, hereditary angiodema, hypertriglyceridemia, mixed hyperlipidemia, hypertriglyceridemia, hypertension, preeclampsia, thromboprophylaxis, hepatitis B virus infection, hepatitis D virus infection, chronic liver infection; Pharmaceuticals, biosimilars and biological preparations for medical and therapeutic purposes for use in the treatment of cancer, HIV, hepatitis A, hepatitis B, influenza, measles, neurodegenerative diseases, transthyretin (TTR)-mediated amyloidosis (ATTR), hemophilia, porphyria, complement-mediated disease, hypercholesterolemia, rare genetic diseases, cardio-metabolic diseases, hepatic infectious diseases, hereditary ATTR amyloidosis, rare bleeding disorders, hepatic porphyrias, alpha-1 antitrypsin deficiency, primary hyperoxaluria type 1, beta-thalassemia, iron overload disorders, hereditary angiodema, hypertriglyceridemia, mixed hyperlipidemia, hypertriglyceridemia, hypertension, preeclampsia, thromboprophylaxis, hepatitis B virus infection, hepatitis D virus infection, chronic liver infection.